Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 3.7T | 3.4T | 3.3T | 3.1T |
Cost of revenue | 761.0B | 742.2B | 727.2B | 705.1B |
Gross profit | 2.9T | 2.6T | 2.5T | 2.4T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.0T | 1.7T | 1.7T | 1.5T |
Operating income | 449.6B | 536.4B | 476.5B | 474.8B |
Non operating interest income | ||||
Income | 22.5B | 8.8B | 5.8B | 126.8B |
Expense | 36.8B | 35.1B | 27.6B | 31.1B |
Other income expense | — | — | — | — |
Pretax income | 423.6B | 517.7B | 461.6B | 577.5B |
Tax provision | 133.3B | 160.4B | 154.3B | 187.4B |
Net income | 290.4B | 357.3B | 307.3B | 390.2B |
Basic EPS | — | 4.0 | 3.5 | 4.4 |
Diluted EPS | — | 4.0 | 3.5 | 4.4 |
Basic average shares | — | 84.6B | 85.3B | 85.2B |
Diluted average shares | — | 84.6B | 85.3B | 85.2B |
EBITDA | 899.5B | 961.1B | 888.0B | 1.0T |
Net income from continuing op. | 290.4B | 357.3B | 307.3B | 390.2B |
Minority interests | -22.0B | -17.0B | -12.2B | -14.4B |
Preferred stock dividends | 0 | 0 | 0 | 0 |